The Comparison of the Efficacy of Baloxavir and Neuraminidase Inhibitors for Patients with Influenza A in Clinical Practice

OBJECTIVE: Baloxavir marboxil is a novel anti-influenza drug reported to have an early antiviral effect, although it also causes the appearance of variant viruses with a reduced susceptibility to baloxavir. In Japan, four neuraminidase inhibitors (NAIs) have been commonly used to treat patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Yoshii, Naoko, Tochino, Yoshihiro, Fujioka, Masashi, Sakazaki, Hiromi, Maruyama, Naomi, Asai, Kazuhisa, Kakeya, Hiroshi, Shintaku, Haruo, Kawaguchi, Tomoya
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364256/
https://ncbi.nlm.nih.gov/pubmed/32536677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.4117-19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars